Centogene N.V. Cash and Cash Equivalents 2011-2026 | CNTG

Annual Cash and Cash Equivalents Centogene N.V.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19.1 M	36 M	17.8 M	48.2 M	41.1 M	9.22 M	3.16 M	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
48.2 M	3.16 M	24.9 M

Quarterly Cash and Cash Equivalents Centogene N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	42.7 M	17.8 M	25.7 M	34.8 M	45.2 M	48.2 M	28.7 M	17.4 M	33.4 M	41.1 M	6.06 M	3.56 M	5.14 M	9.22 M	-	-	-	3.16 M	-	-	-	965 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
48.2 M	965 K	22.7 M

Cash and Cash Equivalents of other stocks in the Diagnostics research industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
ICON Public Limited Company ICLR	752 M	$ 98.33	0.9 %	$ 8.11 B	Irlanda
Akumin AKU	59.4 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	13.3 M	-	-6.19 %	$ 10.5 M	USA
Brainsway Ltd. BWAY	69.3 M	$ 13.71	-0.22 %	$ 99.4 M	Israel
Charles River Laboratories International CRL	214 M	$ 155.46	1.83 %	$ 7.71 B	USA
Bioventus BVS	51.2 M	$ 8.62	0.23 %	$ 574 M	USA
DexCom DXCM	918 M	$ 64.24	-1.56 %	$ 25.1 B	USA
Castle Biosciences CSTL	120 M	$ 25.56	0.95 %	$ 710 M	USA
CareDx, Inc CDNA	65.4 M	$ 17.01	3.4 %	$ 906 M	USA
Accelerate Diagnostics AXDX	34.9 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	956 M	$ 103.57	0.29 %	$ 19.5 B	USA
Guardant Health GH	378 M	$ 85.49	1.75 %	$ 10.7 B	USA
Global Cord Blood Corporation CO	6.66 B	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.7 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	176 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	55.1 M	$ 14.77	0.61 %	$ 447 M	USA
Biodesix BDSX	26.2 M	$ 17.88	-6.63 %	$ 2.32 B	USA
Anixa Biosciences ANIX	1.24 M	$ 2.83	-1.05 %	$ 91.8 K	USA
Danaher Corporation DHR	4.62 B	$ 187.32	0.57 %	$ 134 B	USA
IQVIA Holdings IQV	1.98 B	$ 164.72	1.1 %	$ 28.3 B	USA
Biocept BIOC	12.9 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	157 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	12.2 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	1.13 B	$ 118.94	2.92 %	$ 18.9 B	USA
Quest Diagnostics Incorporated DGX	420 M	$ 199.7	-0.46 %	$ 22.2 B	USA
QIAGEN N.V. QGEN	598 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	1.48 B	$ 111.51	-0.06 %	$ 33.9 B	USA
BioNano Genomics BNGO	9.17 M	$ 1.11	-0.89 %	$ 1.41 M	USA
DarioHealth Corp. DRIO	36.8 M	$ 9.0	-0.99 %	$ 255 M	Israel
Neogen Corporation NEOG	129 M	$ 9.09	-2.78 %	$ 1.97 B	USA
National Research Corporation NRC	4.14 M	$ 16.52	0.12 %	$ 370 M	USA
Chembio Diagnostics CEMI	18.2 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	7.7 M	-	-	$ 9.42 M	Israel
Pacific Biosciences of California PACB	63.7 M	$ 1.33	4.72 %	$ 399 M	USA
Co-Diagnostics CODX	14.9 M	-	-	$ 79.8 M	USA
Medpace Holdings MEDP	497 M	$ 450.41	1.48 %	$ 13 B	USA
Celcuity CELC	22.5 M	$ 114.22	3.11 %	$ 4.51 B	USA
DermTech DMTK	36.7 M	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.9 M	$ 1 173.74	0.49 %	$ 24.2 B	Schweiz
Personalis PSNL	91.4 M	$ 6.72	1.97 %	$ 398 M	USA
NeoGenomics NEO	160 M	$ 7.88	-1.25 %	$ 1.01 B	USA
Enzo Biochem ENZ	52.4 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	466 M	$ 187.85	-1.29 %	$ 18.5 B	USA
Sotera Health Company SHC	345 M	$ 13.42	0.71 %	$ 3.81 B	USA
Invitae Corporation NVTA	257 M	-	-	$ 21.2 M	USA
OPKO Health OPK	427 M	$ 1.19	2.59 %	$ 826 M	USA